CL2012000362A1 - Extracto o fracciones del mismo de la materia vegetal de la familia de plantas de scrophulariaceae para la prevencion, eliminacion y tratamiento de virus a base de adn o arn en general; fracción que se obtienen por cromatografia líquida o gaseosa; uso para tratar infeciones provocadas por virus, hongos, bacterias y protozoos; proceso de extracción. - Google Patents

Extracto o fracciones del mismo de la materia vegetal de la familia de plantas de scrophulariaceae para la prevencion, eliminacion y tratamiento de virus a base de adn o arn en general; fracción que se obtienen por cromatografia líquida o gaseosa; uso para tratar infeciones provocadas por virus, hongos, bacterias y protozoos; proceso de extracción.

Info

Publication number
CL2012000362A1
CL2012000362A1 CL2012000362A CL2012000362A CL2012000362A1 CL 2012000362 A1 CL2012000362 A1 CL 2012000362A1 CL 2012000362 A CL2012000362 A CL 2012000362A CL 2012000362 A CL2012000362 A CL 2012000362A CL 2012000362 A1 CL2012000362 A1 CL 2012000362A1
Authority
CL
Chile
Prior art keywords
dna
viruses
protozoa
fungi
fractions
Prior art date
Application number
CL2012000362A
Other languages
English (en)
Inventor
Munisekhar Divi Satyasayee Babu Medasani
Original Assignee
Medasani Munisekhar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medasani Munisekhar filed Critical Medasani Munisekhar
Publication of CL2012000362A1 publication Critical patent/CL2012000362A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/68—Plantaginaceae (Plantain Family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/80—Scrophulariaceae (Figwort family)
    • A61K36/808—Scrophularia (figwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • A61P33/06—Antimalarials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/30—Extraction of the material
    • A61K2236/35—Extraction with lipophilic solvents, e.g. Hexane or petrol ether
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Obesity (AREA)
  • AIDS & HIV (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2012000362A 2009-08-12 2012-02-10 Extracto o fracciones del mismo de la materia vegetal de la familia de plantas de scrophulariaceae para la prevencion, eliminacion y tratamiento de virus a base de adn o arn en general; fracción que se obtienen por cromatografia líquida o gaseosa; uso para tratar infeciones provocadas por virus, hongos, bacterias y protozoos; proceso de extracción. CL2012000362A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1917CH2009 2009-08-12
IN2150CH2009 2009-09-04

Publications (1)

Publication Number Publication Date
CL2012000362A1 true CL2012000362A1 (es) 2014-05-16

Family

ID=54261174

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2012000362A CL2012000362A1 (es) 2009-08-12 2012-02-10 Extracto o fracciones del mismo de la materia vegetal de la familia de plantas de scrophulariaceae para la prevencion, eliminacion y tratamiento de virus a base de adn o arn en general; fracción que se obtienen por cromatografia líquida o gaseosa; uso para tratar infeciones provocadas por virus, hongos, bacterias y protozoos; proceso de extracción.

Country Status (20)

Country Link
US (1) US9433656B2 (es)
EP (1) EP2482832A4 (es)
JP (2) JP2013501776A (es)
KR (1) KR20120081979A (es)
CN (3) CN102481328A (es)
AP (1) AP3784A (es)
AU (1) AU2010288101B2 (es)
BR (1) BR112012002836A2 (es)
CA (1) CA2769751A1 (es)
CL (1) CL2012000362A1 (es)
CO (1) CO6511230A2 (es)
DO (1) DOP2012000036A (es)
EA (1) EA030607B1 (es)
IL (1) IL217944B (es)
MX (1) MX344305B (es)
MY (1) MY175245A (es)
NZ (1) NZ598244A (es)
SG (2) SG10201404811SA (es)
WO (1) WO2011024196A2 (es)
ZA (1) ZA201201373B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013042131A1 (en) 2011-09-23 2013-03-28 M KUMAR, Anil A process for preparation of synergistic herbal preparation of extracts picrorhiza kurroa and glycyrrhiza glabra having medicinal value
CN103571824B (zh) * 2012-08-09 2016-04-13 财团法人工业技术研究院 用于分离核酸的组合物及方法
CN102920831B (zh) * 2012-11-20 2014-07-23 济南康众医药科技开发有限公司 一种胡黄连总皂苷的制备方法
EP2983683A4 (en) * 2013-04-08 2017-03-01 Munisekhar Medasani Bioactive apolar extract containing plant genetic material for treatment of mammalian diseases
CN109762353A (zh) * 2019-01-08 2019-05-17 北京盛广拓再生科技股份有限公司 冬季冷补料及生产工艺
WO2021152555A1 (en) * 2020-02-02 2021-08-05 Munisekhar Medasani Novel immunotherapy for tumours and cancers, and associated inflammation
CN116264823A (zh) * 2020-07-20 2023-06-16 穆尼塞克哈尔·梅达萨尼 非编码RNAs，淋巴细胞，中性粒细胞，炎性小体和p53基因的调节
EP4176867A1 (fr) * 2021-11-03 2023-05-10 Term Helvet SA Extrait de plante et son utilisation dans des compositions à usage topique
TR2022005910A2 (tr) * 2022-04-13 2023-10-23 İstanbul Tekni̇k Üni̇versi̇tesi̇ Malzemeleri̇n yağ tutma kapasi̇tesi̇ni̇ arttirmak üzere verbascum ekstraktinin kullanilmasi
CN119015352B (zh) * 2024-08-19 2025-12-12 山东大学 一种利用n-甲基吡咯烷酮提取茶多酚的方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5145955A (en) * 1991-10-28 1992-09-08 Council Of Scientific & Industrial Research Process for the preparation and composition of a fraction containing picroside I and kutkoside
US6696094B2 (en) * 2000-10-18 2004-02-24 Tzu-Sheng Wu Herbal pharmaceutical composition for treatment of HIV/AIDS patients
EP1370272A1 (en) * 2001-03-02 2003-12-17 Biopharmacopae Design International Inc. Inhibitors of extracellular proteases
US6855346B2 (en) * 2001-10-05 2005-02-15 Tzu-Sheng Wu Pharmaceutical composition having prophylactic effects on lamivudine-related disease relapse and drug resistance and methods of using the same
US20060246161A1 (en) * 2003-02-21 2006-11-02 Hongtao Xing Method of making medicament for treating anemia
CN1488637A (zh) * 2003-09-05 2004-04-14 北京深文医药科技开发有限公司 一种胡黄连总苷提取物的制备方法
CN100398121C (zh) * 2004-12-15 2008-07-02 周亚伟 胡黄连提取物在制备治疗糖尿病药物中的应用
CN1699392B (zh) * 2005-06-13 2011-06-29 中国医药研究开发中心有限公司 胡黄连总苷的制备方法
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
CN100493539C (zh) * 2006-08-24 2009-06-03 南方医科大学 西藏胡黄连在制备治疗肾脏疾病药物中的应用
US20080207578A1 (en) * 2006-12-15 2008-08-28 Chu Kee Hung Method of inducing apoptosis in cancer treatment by using cucurbitacins
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.

Also Published As

Publication number Publication date
EP2482832A2 (en) 2012-08-08
CN105902672A (zh) 2016-08-31
ZA201201373B (en) 2013-01-30
MY175245A (en) 2020-06-17
WO2011024196A2 (en) 2011-03-03
US9433656B2 (en) 2016-09-06
MX2012001747A (es) 2012-06-12
DOP2012000036A (es) 2012-07-15
CN105878538A (zh) 2016-08-24
AP3784A (en) 2016-08-31
CO6511230A2 (es) 2012-08-31
SG10201404811SA (en) 2014-09-26
BR112012002836A2 (pt) 2015-09-01
JP2016028104A (ja) 2016-02-25
CA2769751A1 (en) 2011-03-03
CN102481328A (zh) 2012-05-30
NZ598244A (en) 2015-03-27
KR20120081979A (ko) 2012-07-20
US20120219648A1 (en) 2012-08-30
AP2012006179A0 (en) 2012-04-30
JP2013501776A (ja) 2013-01-17
WO2011024196A3 (en) 2011-06-16
EA030607B1 (ru) 2018-08-31
SG178235A1 (en) 2012-03-29
IL217944B (en) 2018-06-28
EP2482832A4 (en) 2013-10-02
IL217944A0 (en) 2012-03-29
MX344305B (es) 2016-12-13
AU2010288101B2 (en) 2016-01-14
AU2010288101A1 (en) 2012-03-08
EA201270273A1 (ru) 2012-09-28

Similar Documents

Publication Publication Date Title
CL2012000362A1 (es) Extracto o fracciones del mismo de la materia vegetal de la familia de plantas de scrophulariaceae para la prevencion, eliminacion y tratamiento de virus a base de adn o arn en general; fracción que se obtienen por cromatografia líquida o gaseosa; uso para tratar infeciones provocadas por virus, hongos, bacterias y protozoos; proceso de extracción.
BRPI1006393A2 (pt) Uso de ao menos um filtro uv, metodo de combate a fungos e/ou bacterias nocivos em uma planta cultivada, método de redução dos sintomas de doença fotodependente e composição que compreende um solvente ou carregador e ao menos um filtro uv
MY182771A (en) Viral replication inhibitors
BR112017020604A2 (pt) cepa de paenibacillus inovadora, compostos antifúngicos e métodos para seu uso
ECSP17064986A (es) Compuestos antivirales
PH12015502230B1 (en) Novel viral replication inhibitors
WO2007109600A3 (en) Extractions and methods comprising elder species
BR112015004311A2 (pt) uso de benzodiazepinonas e benzazepinonas substituídas ou os sais das mesmas como substâncias ativas contra estresse abiótico de planta
MX2012004876A (es) Preparacion que comprende aminoacidos y plantas y su actividad en la detoxificacion del alcohol.
CL2011001210A1 (es) Uso de composiciones fitofarmacéuticas en el tratamiento y/o prevención de infecciones por organismos patógenos en plantas, donde las composiciones comprenden un extracto de semillas de vitis vinífera; y método.
AR087167A1 (es) Genes de resistencia al tizon tardio
MX392300B (es) Elementos reguladores de planta y metodos para usarlos.
AR093103A1 (es) COMPOSICION A BASE DE HIERBAS PARA LA PREVENCION Y TRATAMIENTO DE FACTOR a DE NECROSIS TUMORAL (TNF-a) UNA ENFERMEDAD MEDIADA
Al Bahtiti Chemical analysis and biological activity of Jordanian chamomile extracts
MX2014010926A (es) Composicion herbaria para el tratamiento de transtornos metabolicos.
AP2012006180A0 (en) Picrorhiza kurroa extract for prevention, elimination and treatment of RNA viruses and infection or diseases caused by the same in humans, animals andin biotech industry.
BRPI1006987A2 (pt) extrato de cissampelos pareira, uso do mesmo, processo para o preparo do mesmo, fração, composição farmacêutica e método para o tratamento de infecção pelo vírus da dengue.
WO2011096685A3 (ko) 신종플루 바이러스와 조류인플루엔자 바이러스에 대한 불활화능을 가진 약쑥 95%주정추출물이 함유된 쑥환
ES2557813B2 (es) Composición iniciadora de la fermentación que comprende cepas de microorganismos libres e inmovilizados
WO2012131728A3 (en) A herbal medication to cure bloat in animals
BR112014014963A2 (pt) sistema de ativação líquido
BR112018014323A2 (pt) uso de substâncias ativas para controlar infecções virais em plantas
RU2018104859A (ru) Растительный препарат для лечения ран и его применение
Ghazali et al. Toxicological Profi le of Hexane Extract of Alpinia conchigera (Small Ginger) In vitro
WO2014008901A3 (ar) استخدام الخرشوف الصحراوي في القضاء على الألتهاب الكبدى الوبائى (فيروس سى)